FrancophonIA/ELRC3.0 huggingface dataset:
English: aureus in commercial dairy herds was investigated.
Maltese: Ġew eżaminati mill-ġdid bosta pubblikazzjonijiet u studji proprjetarji.
English: Rabbits:
Maltese: Ħnieżer:
English: Sweden Chanelle Pharmaceuticals Manufacturing Ltd.
Maltese: Chanelle Pharmaceuticals Manufacturing Ltd.
English: Dogs, cats
Maltese: Klieb, qtates
English: S/vet_referral_000067.jsp&mid=WC0b01ac05805c5170 4 Ortega et al. Characterisation and public health risks of antimicrobial resistance in Staphylococcus aureus in intensive rabbit breeding.
Maltese: Id-dokument ta' pożizzjoni tas-CVMP fir-rigward tad-disponibbiltà ta' prodotti għal użi minuri u speċijiet minuri (EMEA/CVMP/477/03)1 jistabbilixxi li l-annimali tal-ifrat (annimali tal-ħalib u tal-laħam) u nnagħaġ (annimali tal-laħam) jitqiesu bħala speċijiet ewlenin għall-produzzjoni tal-ikel.
English: Treatment of acute severe mastitis caused by enrofloxacin susceptible strains of Escherichia coli.
Maltese: Kura ta' mastite akuta severa kkawżata minn razez suxxettibbli għal enrofloxacin ta' Escherichia coli.
English: The study also unveiled very high resistance to quinolones (around 38% for ciprofloxacin).
Maltese: L-istudju wera wkoll reżistenza għolja ħafna għall-kwinoloni (madwar 38% għal ciprofloxacin).
English: 2.5 mg of enrofloxacin/kg bw corresponding to 1 ml/10 kg bw, once daily by intramuscular injection for 3 days.
Maltese: 2.5 mg ta' enrofloxacin/kg bw, li tikkorrispondi għal 1 ml/10 kg bw, darba kuljum permezz ta' injezzjoni ġol-muskolu għal 3 ijiem.
English: Treatment of infections of the alimentary, respiratory and urogenital tracts (as adjunctive antibiotic therapy for pyometra), skin and wound infections, caused by enrofloxacin susceptible strains of, e.g.: Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp.
Maltese: Kura ta' infezzjonijiet fil-passaġġi alimentari, respiratorji u uroġenitali (inkluż terapija antibijotika aġġuntiva għall-pjometrija), infezzjonijiet fil-ġilda u l-feriti, ikkawżati minn razez suxxettibbli għal enrofloxacin ta', eż: Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp.
English: - Dosage: 2.5 mg/kg bw, once daily for 3 days by intramuscular injection.
Maltese: 2.5 mg/kg bw, darba kuljum għal 3 ijiem permezz ta' injezzjoni ġol-muskolu.
English: Meat and offal (25 mg/ml strength): Two residue depletion studies were provided, but only in one of the studies were the animals treated at the recommended dose of 10 mg/kg bw for up to 10 days.
Maltese: Laħam u l-ġewwieni (qawwa ta' 25 mg/ml): Ġew ipprovduti żewġ studji dwar it-tnaqqis tar-residwi, iżda f'wieħed mill-istudji biss l-annimali ġew ikkurati bid-doża rrakkomandata ta' 10 mg/kg bw għal perjodu sa 10 ijiem.
English: A withdrawal period of 72 hours (3 days) is recommended for sheep milk for animals treated at the recommended dose of 5 mg/kg bw with the 50 mg/ml and 100 mg/ml strengths by subcutaneous injection.
Maltese: Għalhekk, huwa rakkomandati perjodu ta' tiżmim ta' 72 siegħa (3 ijiem) għall-ħalib mill-annimali tal-ifrat kkurati bid-doża rrakkomandata ta' 5 mg/kg bw/jum bil-qawwa ta' 100 mg/ml ġol-vina.
English: Calves (50 mg/ml strength)
Maltese: Għoġġiela (qawwa ta' 50 mg/ml)
English: Two different doses were examined: 2.5 mg/kg bw and 5 mg/kg bw, twice daily for 3 consecutive days.
Maltese: 2.5 mg/kg bw u 5 mg/kg bw, darbtejn kuljum għal 3 ijiem konsekuttivi.
English: and Histophilus somni (50 mg/ml and 100 mg/ml strengths)
Maltese: Nagħaġ (qawwiet ta' 50 mg/ml u 100 mg/ml)
English: Treatment of infections of the alimentary, respiratory and urogenital tracts (as adjunctive antibiotic therapy for pyometra), skin and wound infections, caused by enrofloxacin susceptible strains of: Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp.
Maltese: Kura ta' infezzjonijiet fil-passaġġi alimentari, respiratorji u uroġenitali (inkluż terapija antibijotika aġġuntiva għall-pjometrija), infezzjonijiet fil-ġilda u l-feriti, ikkawżati minn razez suxxettibbli għal enrofloxacin: Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp.
English: As regards to Mycoplasma bovis, this microorganism is difficult to be identified and assessed since it is often involved in mixed infections.
Maltese: Fir-rigward ta' Mycoplasma bovis, huwa diffiċli li jiġi identifikat u indirizzat dan il-mikroorganiżmu minħabba li ta' spiss ikun involut f'infezzjonijiet imħallta.
English: Piglets (25 mg/ml strength)
Maltese: Fniek (qawwa ta' 25 mg/ml)
English: A. For products listed in Annex I containing 25 mg enrofloxacin per ml
Maltese: Għal prodotti elenkati fl-Anness I li jkun fihom 25 mg enrofloxacin għal kull ml
English: Following intravenous injection:
Maltese: Инжекционен разтвор
English: Replication forks and translational complexes cannot proceed beyond such enzyme-DNA-fluoroquinolone complexes, and inhibition of DNA and mRNA synthesis triggers events resulting in a rapid, drug concentration-dependent killing of pathogenic bacteria.
Maltese: Il-frieket tar-replikazzjoni u lkumplessi tat-traduzzjoni ma jistgħux jipproċedu lil hinn minn dawn il-kumplessi ta' enzimi-DNAfluoroquinolone, u l-inibizzjoni tas-sintesi tad-DNA u tal-mRNA tibda avvenimenti li jwasslu għall-qtil mgħaġġel, dipendenti fuq il-konċentrazzjoni tal-mediċina, tal-batterji patoġeniċi.
English: aureus following use of the product in food rabbits was considered: - In a study 4.2% of 71 isolates of Staph.
Maltese: L-ogħla rata ta' suċċess ġiet osservata fl-għoġġiela ≤ sentejn (71,4%), iżda naqqset fl annimali li għandhom iktar żmien.
English: Enrofloxacin showed better clinical results than oxytetracyclin at all dose levels, with a more rapid decrease of total clinical scores and faecal consistency scores.
Maltese: Enrofloxacin wera riżultati kliniċi aħjar minn oxytetracyclin fil-livelli tad-dożi kollha, bi tnaqqis iktar mgħaġġel tal-punteġġi kliniċi u l-punteġġi ta' konsistenza tal-feċi.
English: Quinta da Beloura 2710-444 Sintra PORTUGAL
Maltese: Quinta da Beloura 2710-444
English: Hoge Mauw 900, 2370 Arendonk BELGIUM
Maltese: Leo Aerden Hoge Mauw 900, 2370 Arendonk BELGIUM
English: Biochemiestrasse 10, 6250 Kundl AUSTRIA
Maltese: Biochemiestrasse 10, 6250
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
Maltese: U KWANTITATTIVA Sustanza attiva:
English: c/De la Marina, 206 08013 Barcelona SPAIN
Maltese: Novartis Sanidad Animal, S.L. c/De la Marina, 206 08013 Barcelona SPAIN
English: Largo Umberto Boccioni, 1 21040 Origlio (Varese) ITALY
Maltese: Largo Umberto Boccioni, 1 21040
English: • 10% and
Maltese: • 10% u
English: Amount of tiamulin hydrogen fumarate (mg/g) per premix formulation
Maltese: Amount of taimulin idroġen fumarat (mg/g) per premix formulation
English: Contraindication
Maltese: KONTRAINDIKAZZJONIJIET
English: Tiamulin has shown in-vitro activity against a wide range of bacteria including Brachyspira hyodysenteriae, Brachyspira pilosicoli, Lawsonia intracellularis and Mycoplasma spp.
Maltese: Tiamulin wera attività in-vitro kontra firxa wiesgħa ta' batterji inkluż Brachyspira hyodysenteriae, Brachyspira pilosicoli, Lawsonia intracellularis u Mycoplasma spp.
English: Tiamulin is well absorbed in chickens (70-95%) after oral administration.
Maltese: Tiamulin huwa assorbit sew fit-tiġieġ (70-95%) wara amministrazzjoni orali.
English: In breeders on 0.025% tiamulin the average serum level was 0.36μg/ml (range 0.22-0.5μg/ml).
Maltese: Fit-tjur għat-tgħammir fuq tiamulin ta' 0.025% il-livell medju tas-serum kien 0.36μg/ml (medda 0.22-0.5μg/ml).
English: antibacterial for systemic use
Maltese: antibatteriku għal użu sistemiku
English: The Codex Code of practice to minimize and contain antimicrobial resistance (CAC/RCP 61-2005), OIE Guidelines for the responsible and prudent use of antimicrobial agents in veterinary medicine, and Federation of Veterinarians of Europe: Antibiotic Resistance & Prudent use of Antibiotics in Veterinary Medicine)
Maltese: Il-Kodiċi Codex ta' prattika għat-tnaqqis u t-trażżin ta' reżistenza antimikrobjali (CAC/RCP 61-2005), il-Linji Gwida OIE għall-użu responsabbli u prudenti ta' sustanzi antimikrobjali filmediċina veterinarja, u l-Federazzjoni tal-Veterinarji fl-Ewropa:
English: Following a single oral dose of 10 mg and 25 mg tiamulin/kg bodyweight the Cmax was 1.03 μg/ml and 1.82 μg/ml respectively by microbiological assay and the Tmax was 2 hours for both.
Maltese: Wara doża orali singola ta' 10 mg u 25 mg tiamulin/kg bwt is-Cmax kien 1.03 μg/ml u 1.82 μg/ml rispettivament permezz ta' analiżi mikrobijoloġika u t-Tmax kien ta' sagħtejn għat-tnejn.
English: Treatment of Swine Dysentery caused by B. hyodysenteriae, treatment of Porcine Colonic Spirochaetosis (colitis) caused by B. pilosicoli
Maltese: Trattament ta' Diżenterija tal-Majjali kkawżata minn B. hyodysenteriae, trattament tal-Porcine Colonic Spirochaetosis (kolite) ikkawżata minn B. pilosicoli
English: IRELAND
Maltese: Irlanda
English: Excretion is mainly via the bile (55-65%) and kidney (15-30%) as mainly microbiologically inactive metabolites and is quite rapid, 99% of the dose within 48 hours.
Maltese: It-tneħħija ssir prinċipalment permezz tal-bili (55-65%) u l-kliewi (15-30%) l-aktar bħala metaboliti mhux attivi mikrobijoloġikament u tkun pjuttost mgħaġġla, 99% tad-doża fi żmien 48 siegħa.
English: Tiamutin 10% premiks leczniczy dla świń
Maltese: Tiamutin 10% premiks leczniczy dla świń Premix
English: It should be noted that the 0.65% strength currently authorised in France is covered by the 0.8% Premix SPC/label (0.65% tiamulin base is eqivalent to 0.8% tiamulin hydrogen fumarate) and the 1.62% strength currently authorized in France is covered by the 2% Premix SPC/label (1.62% tiamulin base is eqivalent to 2 % tiamulin hydrogen fumarate).
Maltese: Ta' min jinnota li l-konċentrazzjoni ta' 0.65% li fil-preżent hija awtorizzata fi Franza hija koperta mill-SPC/tikketta tat-Taħlita ta' 0.8% (0.65% bażi ta' tiamulin hija ekwivalenti għal 0.8% taimulin idroġen fumarat) u l-konċentrazzjoni ta' 1.62% li fil-preżent hija awtorizzata fi Franza hija koperta mill-SPC/tikketta tat-Taħlita ta' 2% (1.62% bażi ta' tiamulin hija ekwivalenti għal 2% tiamulin idroġen fumarat).
English: Secondary infection by organisms such as Pasteurella multocida and Actinobacillus pleuropneumoniae may complicate enzootic pneumonia and require specific medication.
Maltese: Infezzjoni sekondarja permezz ta' organiżmi bħal Pasteurella multocida u Actinobacillus pleuropneumoniae tista' tikkomplika l-pnewmonja enżootika u tkun teħtieġ medikazzjoni speċifika.
English: Belgium VMD nv Leo Aerden
Maltese: VMD nv
English: 1. to provide an exhaustive list of differences between the SPCs of the product authorised in the Member States; 2. to review all sections of the SPCs and to suggest appropriate changes in the text where divergences exist and to propose a harmonised Product Information (SPC and labelling), taking into account the latest guidance; 3. to provide available relevant data, in particular substantiating such proposed harmonised Product Information in relation to the discrepancies identified above.
Maltese: Jirrevedu s-sezzjonijiet kollha tal-SPCs u jissuġġerixxu bidliet xierqa fil-kitba fejn jeżistu ddifferenzi u jipproponu Informazzjoni armonizzata dwar il-Prodott (SPC u tikkettar), filwaqt li jikkunsidraw l-aktar gwida reċenti; 3.
English: Meat and offal: 1 day Eggs: 0 days
Maltese: Laħam u offal: 1 jum Bajd: 0 jiem
English: Rabbits:
Maltese: Tjur:
English: Tiamulin has been shown to concentrate in the lung, a target tissue and also in liver, where it is metabolised and excreted (70-85%) in the bile, the remainder is excreted via the kidney (15-30%).
Maltese: Tiamulin intwera li jikkonċentra fil-pulmun, tessut fil-mira u wkoll fil-fwied, fejn jiġi metabolizzat u jitneħħa fil-bili (70-85%), il-bqija jitneħħa permezz tal-kliewi (15-30%).
English: Calculations to achieve the correct dose rate and achieve the correct inclusion rate should be based on: - Inclusion rate (ppm) = dose rate (mg/kg bodyweight) x bodyweight (kg) / daily feed intake (kg)
Maltese: Rata ta' inklużjoni (ppm) = rata tad-doża (mg/kg bwt) x piż talġisem (kg) / konsum ta' għalf kuljum (kg)
English: Tiamulin is bacteriostatic at therapeutic concentrations and has been shown to act at the 70S ribosome level and the primary binding site is on the 50S subunit and possibly a secondary site where the 50S and 30S subunits join.
Maltese: Tiamulin huwa batterjostatiku f'konċentrazzjonijiet terapewtiċi u ntwera li jaġixxi fil-livell tarribożoma 70S u s-sit ta' rbit primarju huwa fuq is-subunità 50S u possibbilment fuq sit sekondarju fejn jingħaqdu s-subunitajiet 50S u 30S.
English: The Marketing Authorisation Holders were requested:
Maltese: Id-Detenturi tal-Awtorizzazzjoni għat-Tqegħid fis-Suq intalbu:
English: Chickens and turkeys: The LD5 for chickens is 1290mg/kg and turkeys 840 mg/kg bodyweight.
Maltese: L-LD5 għat-tiġieġ huwa ta' 1290mg/kg u għad-dundjani 840 mg/kg piż tal-ġisem.
English: Dosage: 3 mg tiamulin hydrogen fumarate /kg body weight daily.
Maltese: Dożaġġ: 3 mg tiamulin hydrogen fumarate /kg piż tal-ġisem kuljum.
English: In France the registered 0.65% premix refers to tiamulin base equivalent to a premix containing 0.8% tiamulin hydrogen fumarate, and the registered 1.62% premix refers to tiamulin base which is equivalent to a premix containing 2.0 % tiamulin hydrogen fumarate.
Maltese: Fi Franza t-taħlita lesta rreġistrata ta' 0.65% tirreferi għal bażi ta' tiamulin ekwivalenti għal taħlita lesta li fiha 0.8% taimulin idroġen fumarat, u t-taħlita lesta rreġistrata ta' 1.62% tirreferi għal bażi ta' tiamulin li hija ekwivalenti għal taħlita lesta li fiha 2.0 % taimulin idroġen fumarat.
English: Treatment should be administered until 2 - 3 days after clinical signs has resolved.
Maltese: It-trattament għandu jingħata sa 2 - 3 ijiem wara li s-sintomi kliniċi jkunu għebu.
English: Personal protective equipment should be worn when mixing the veterinary medicinal product or handling the medicated feed: overalls, impervious gloves and either a disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator conforming to European Standard EN 140, with a filter to European Standard EN 143.
Maltese: Waqt it-taħlit tal-prodott mediċinali veterinarju jew waqt il-maniġġ tal-għalf medikat għandu jintlibes apparat ta' protezzjoni personali: overalls, ingwanti li ma jgħaddix l-ilma minnhom u, jew respiratur f'għamla ta' nofs maskra li tintrema wara l-użu u li tkun konformi mal-Istandard Ewropew EN 149 jew respiratur li ma jintremiex wara l-użu u li jkun konformi mal-Istandard Ewropew EN 140, b'filtru tal-Istandard Ewropew EN 143.
English: Turkeys Chickens
Maltese: Majjali Fniek
English: Turkeys Meat and offal: 4 days
Maltese: Dundjani Laħam u offal: 4 jiem
English: For the treatment and prevention of epizootic rabbit enterocolitis (ERE)
Maltese: Għat-trattament u l-prevenzjoni ta' enterokolite epiżootika tal-fniek (epizootic rabbit enterocolitisERE)
English: Chickens
Maltese: Fniek
English: Chickens (broiler, replacement pullet, laying and breeding hens) Treatment and prevention of chronic respiratory disease (CRD) caused by M. gallisepticum and airsacculitis and infectious synovitis caused by M. synoviae.
Maltese: Tiġieġ (brojlers, għattuq ta' sostituzzjoni, dawk li jbidu/dawk għat-tgħammir) Għat-trattament u l-prevenzjoni ta' Mard Respiratorju Kroniku(CRD) ikkawżat minn M. gallisepticum u sakkulite tal-arja u sinovite infettiva kkawżati minn M. synoviae.
English: Rabbits There are no pharmacokinetic data available for rabbits.
Maltese: Fniek M'hemmx dejta farmakokinetika disponibbli fil-każ tal-fniek.
English: PHARMACOLOGICAL PROPERTIES Pharmacotherapeutic group:
Maltese: Grupp farmakoterapewtiku:
English: • Chickens
Maltese: • Tiġieġ
English: Pigs: Single oral doses of 100 mg/kg body weight in pigs caused hyperpnoea and abdominal discomfort.
Maltese: Majjali: Dożi orali singoli ta' 100 mg/kg piż tal-ġisem fil-majjali kkawżaw iperpneja u skonfort addominali.
English: 4.4 Special warning for each target species
Maltese: 4.5 Prekawzjonijiet Speċjali għall-Użu
English: Dosage: 5 - 10 mg tiamulin hydrogen fumarate/kg bodyweight daily administered for 7 to 10 consecutive days.
Maltese: Dożaġġ: 5 - 10 mg tiamulin hydrogen fumarate/kg piż tal-ġisem kuljum mogħti għal 7 sa 10 ijiem konsekuttivi.
English: For the treatment and prevention of chronic respiratory disease (CRD) and airsacculitis caused by Mycoplasma gallisepticum and Mycoplasma synoviae
Maltese: Għat-trattament u l-prevenzjoni ta' Mard Respiratorju Kroniku (Chronic Respiratory Disease - CRD) u sakkulite tal-arja kkawżati minn Mycoplasma gallisepticum u Mycoplasma synoviae
English: Turkeys
Maltese: Biss
English: Tiamulin distributes widely through the body and has been shown to concentrate in the liver and kidney (sites of excretion) and in the lung (30 times serum level).
Maltese: Tiamulin jinfirex sew matul il-ġisem u ntwera li jikkonċentra fil-fwied u fil-kliewi (siti ta' tneħħija) u fil-pulmun (30 darba l-livell tas-serum).
English: Wash contaminated skin.
Maltese: Aħsel il-ġilda kkontaminata.
English: Withdrawal period(s).
Maltese: Perijodu(i) ta' tiżmim
English: Due to the divergent national decisions taken by Member States concerning the authorisation of these products, the issue was referred to CVMP under Article 34(1) of Directive 2001/82/EC, in order to resolve divergences amongst the nationally authorised Summary of Product Characteristics (SPC) across the European Union.
Maltese: Minħabba d-differenzi fid-deċiżjonijiet nazzjonali meħuda mill-Istati Membri rigward lawtorizzazzjoni ta' dawn il-prodotti, il-kwistjoni ġiet riferuta lis-CVMP skont l-Artikolu 34(1) tadDirettiva 2001/82/KE, sabiex isolvi d-differenzi bejn is-Sommarji tal-Karatteristiċi tal-Prodott (SPC) awtorizzati mill-pajjiżi fl-Unjoni Ewropea.
English: For the treatment and prevention of infectious sinusitis and airsacculitis caused by Mycoplasma gallisepticum, Mycoplasma meleagridis and Mycoplasma synoviae
Maltese: Għat-trattament u l-prevenzjoni ta' sinużite akuta u sakkulite tal-arja kkawżati minn Mycoplasma gallisepticum, Mycoplasma meleagridis u Mycoplasma synoviae
English: Tiamulin is a bacteriostatic semi-synthetic antibiotic belonging to the pleuromutilin group of antibiotics and acts at the ribosomal level to inhibit bacterial protein synthesis.
Maltese: Tiamulin huwa antibijotiku batterjostatiku semi-sintetiku li jappartjeni għall-grupp pleuromutilin ta' antibijotiċi u jaġixxi fil-livell ribosomali sabiex jinibixxi s-sinteżi tal-proteini batteriċi.
English: Rabbits Pigs
Maltese: Ħnieżer
English: The authorised premix-formulations are based on tiamulin hydrogen fumarate in a concentration of:
Maltese: Il-formulazzjonijiet awtorizzati ta' taħlitiet lesti huma bbażati fuq taimulin idroġen fumarat f'konċentrazzjoni ta':
English: The use of tiamutin premix and associated names in the treatment and prevention of swine dysentery, treatment of Porcine Colonic Spirochaetosis (colitis) caused by Brachyspira pilosicoli, treatment of Porcine Proliferative Entheropaty (ileitis) caused by L. intracellularis and treatment of enzootic pneumonia caused by M. hyopneumoniae is agreed.
Maltese: Hemm qbil dwar l-użu tat-taħlita lesta b'tiamutin u l-ismijiet assoċjati fit-trattament u l-prevenzjoni tad-diżenterija tal-majjali, it-trattament tal-Porcine Colonic Spirochaetosis (kolite) kkawżata minn Brachyspira pilosicoli, it-trattament tal-Porcine Proliferative Entheropaty (ileite) ikkawżata minn L. intracellularis u t-trattament ta' pnewmonja enżootika kkawżata minn M. hyopneumoniae.
English: Excipients: For full list of excipients, see section 6.1
Maltese: Għal-lista sħiħa ta' l-ingredjenti mhux attivi, ara s-sezzjoni 6.1
English: Refer to section 4.8 for information regarding interaction between tiamulin and ionophores.
Maltese: Irreferi għas-Sezzjoni 4.8 għal tagħrif dwar l-interazzjoni bejn tiamulin u jonofori.
English: At 150 mg/kg no CNS effects were noted except for sedation.
Maltese: B'150 mg/kg ma ġewx osservati effetti fuq is-CNS ħlief għal sedazzjoni.
English: PHARMACEUTICAL PARTICULARS
Maltese: Għamla Farmaċewtika
English: Rabbits Meat and offal: 0 days
Maltese: Laħam u offal: 0 jiem
English: At 55 mg/kg given for 14 days a transient salivation and slight gastric irritation occurred.
Maltese: B'55 mg/kg mogħtija għal 14-il jum, seħħew salivazzjoni temporanja u irritazzjoni gastrika ħafifa.
English: Chickens (broiler, replacement pullet, layer/breeder) Turkeys (poult (grower) and breeder) Rabbits
Maltese: Tiġieġ (brojlers, għewietaq ta' sostituzzjoni, tiġieġ tal-bajd/tiġieġ għat-tgħammir)
English: 100 mg/g Premix for medicated feed for pigs, chickens, turkeys and rabbits Tiamulin hydrogen fumarate
Maltese: Taħlita bil-lest ta' 100 mg/g għall-għalf medikat għall-majjali, tjur u fniek Tiamulin hydrogen fumarate
English: The use of tiamutin premix and associated names in the treatment and prevention of chronic respiratory disease (CRD) caused by M. gallisepticum and airsacculitis and infectious synovitis caused by M. synoviae is agreed.
Maltese: Trattament u prevenzjoni ta' Mard Respiratorju Kroniku(CRD) ikkawżat minn M. gallisepticum u sakkulite tal-arja u sinovite infettiva kkawżati minn M. synoviae.
English: - the CVMP considered that the SPC should be harmonised in the framework of this referral procedure, while also noting that certain concentrations of the premix formulations are not currently authorised in Member States in certain species e.g. 0.8% concentration not authorised in chickens and turkeys, 80% concentration not authorised in rabbits;
Maltese: - is-CVMP ikkunsidra li l-SPC għandu jkun armonizzat fil-qafas ta' din il-proċedura ta' referenza, filwaqt li nnota wkoll li ċerti konċentrazzjonijiet tal-formulazzjonijiet ta' taħlitiet lesti fil-preżent m'humiex awtorizzati fi Stati Membri f'ċerti speċi eż. il-konċentrazzjoni ta' 0.8% m'hijiex awtorizzata fit-tiġieġ u d-dundjani, il-konċentrazzjoni ta' 80% m'hijiex awtorizzata fil-fniek;
English: Preventive treatment with tiamulin should only be initiated after confirmed infection with M. gallisepticum, M. synoviae or M. meleagridis and then as an aid in the prevention strategy to reduce the clinical signs and mortality from respiratory disease in flocks, where infection in ovum is likely because the disease is known to exist in the parent generation.
Maltese: It-trattament ta' prevenzjoni b'tiamulin għandu jinbeda biss wara li tiġi kkonfermata l-infezzjoni b'M. gallisepticum, M. synoviae jew M. meleagridis u mbagħad bħala għajnuna fl-istrateġija ta' prevenzjoni għat-tnaqqis tas-sintomi kliniċi u l-mortalità minn mard respiratorju fil-qatgħat, fejn linfezzjoni in ovum tkun possibbli minħabba li huwa magħruf li l-marda teżisti fil-ġenerazzjoni talġenituri.
English: Dosage - Treatment and prevention: 25mg tiamulin hydrogen fumarate/kg body weight daily administered for the period of 3 to 5 consecutive days.
Maltese: Doża - Trattament u prevenzjoni: 25mg tiamulin hydrogen fumarate/kg piż tal-ġisem kuljum mogħti għal perijodu ta' 3 sa 5 ijiem konsekuttivi.
English: Prevention (at 2.0 mg/kg bodyweight): Meat and offal: 1 day Treatment (at 5 -10 mg/kg bodyweight): Meat and offal: 6 days
Maltese: Prevenzjoni (bi 2.0 mg/kg bw) : 1 jum Trattament (b'5 -10 mg/kg bw) : 6 jiem
English: Operator warnings
Maltese: Renju Unit
English: Strength
Maltese: Żvezja
English: 20 mg/g Premix for medicated feed for pigs, chickens, turkeys and rabbits Tiamulin hydrogen fumarate
Maltese: Taħlita bil-lest ta' 20 mg/g għall-għalf medikat għall-majjali, tjur u fniek Tiamulin hydrogen fumarate
English: Tiamulin has been shown to interact with ionophores such as monensin, salinomycin and narasin and may result in signs indistinguishable from an ionophore toxicosis.
Maltese: Effetti fuq prodotti mediċinali oħra jew effetti oħra Tiamulin intwera li jinteraġixxi mal-jonofori bħal monensin, salinomycin u narasin u jista' jirriżulta f'sintomi li ma jintgħarfux minn tossikożi tal-jonofori.